Navigation Links
ScinoPharm to Invest in Tanvex Biologics
Date:8/31/2010

ScinoPharm to Invest in Tanvex Biologics -- TAINAN, Taiwan, Aug. 31 /PRNewswire-Asia/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Acquisitions, Mergers and Takeovers Click to view news release full screen  

ScinoPharm to Invest in Tanvex Biologics

 

TAINAN, Taiwan, Aug. 31 /PRNewswire-Asia/ -- ScinoPharm, a leading active pharmaceutical ingredient (API) developer and manufacturer headquartered in Taiwan, today announced an investment into Tanvex Biologics, Inc., a United States company registered in the State of Delaware. ScinoPharm's investment was in the form of tangible assets, intellectual properties, as well as cash.

Tanvex specializes in the development of biosimilars and biobetters, as well as the provision of contract research and contract manufacturing services for biologics. The company is currently establishing a cGMP facility in San Diego, California and will have research centers in both the U.S. and Taiwan. Tanvex is founded by Dr. Allen Chao, the founder and former Chairman and Chief Executive Officer of Watson Pharmaceuticals, Inc.

Dr. Hardy Chan, co-founder and Chief Scientific Officer of ScinoPharm, will become the Chief Executive Officer of Tanvex. Dr. Chao will remain as Executive Chairman of Tanvex.

About ScinoPharm Taiwan

ScinoPharm Taiwan, Ltd. is a leading process R&D and API manufacturing service provider to the global pharmaceutical industry. With research and manufacturing facilities in both Taiwan and mainland China, ScinoPharm offers a wide portfolio of services ranging from custom synthesis for early phase pharmaceutical activities to brand companies as well as APIs for the generic industry. For more information, please visit http://www.scinopharm.com .

About Tanvex Biologics

Tanvex Biologics, LLC is a US-based biopharmaceutical company specializing in the development of biopharmaceuticals.

Media Contact: ScinoPharm Taiwan, Ltd. Sabrian Wu Tel: +886-6-505-2869 Mobile Phone: +886-920-056-385 Email: sabrina.wu@scinopharm.com.tw
'/>"/>

SOURCE ScinoPharm Taiwan, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Signs Agreement to Divest Equity Interest in ScinoPharm
2. ScinoPharm Announces SafeBridge Potent Compound Safety Certification
3. Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference
4. Zimmer Holdings to Present at INVESTIndiana Equity Conference
5. Hill-Rom to Present at the INVESTIndiana Investor Conference
6. Curemark to Present at the Rodman & Renshaw Annual Global Investment Conference
7. JumpStart Ventures Invests In and Provides Entrepreneurial Assistance to Drug Development Company
8. Advanced Life Sciences Featured as Special Stock Pick by KonLin Investment Letter
9. Sangon & Bio Basic Inc. Closes $10 Million Round of Investment by Qiming Ventures
10. Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC
11. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun ... NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is ... is geared towards children of all ages; it is a non-competitive, non-timed event, which ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):